▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁pat 7.84765625
ie 2.638671875
H 7.23828125
nt 6.8046875
s 0.54833984375
▁receiving 6.24609375
▁ph 6.72265625
arma 1.9208984375
ce 0.031707763671875
ut 0.029876708984375
ical 0.01055908203125
▁op 4.5078125
io 0.190673828125
ids 0.57861328125
▁and 2.53515625
▁medical 6.11328125
▁mar 1.3876953125
iju 0.06439208984375
ana 0.00759124755859375
▁( 4.390625
MM 0.95751953125
) 3.0546875
▁as 2.9140625
▁severe 9.6328125
▁pain 1.46875
kill 3.623046875
ers 0.006465911865234375
. 0.6572265625
▁It 3.279296875
▁comp 5.234375
ares 0.047119140625
▁the 0.681640625
▁effic 6.5546875
acy 0.01520538330078125
▁of 0.25439453125
▁pres 5.0859375
cri 2.14453125
ptions 0.88623046875
▁and 2.29296875
▁exam 6.0234375
ines 0.0121612548828125
▁the 0.468994140625
▁possibility 4.1015625
▁of 0.1094970703125
▁post 6.97265625
- 0.71484375
tre 2.521484375
at 0.015899658203125
ment 0.025146484375
▁de 2.04296875
pression 0.08453369140625
. 1.78125
<0x0A> 2.498046875
There 4.9453125
▁is 1.0322265625
▁currently 4.55078125
▁a 1.2001953125
▁severe 4.9375
▁lack 3.337890625
▁of 0.028900146484375
▁information 2.18359375
▁about 1.400390625
▁the 0.51171875
▁effects 2.83984375
▁of 0.073974609375
▁op 1.7080078125
i 3.78125
ates 0.2000732421875
. 3.830078125
▁They 4.88671875
▁manage 9.1015625
▁pain 3.4609375
▁successfully 5.7109375
, 1.0791015625
▁but 0.322021484375
▁the 2.689453125
▁past 9.453125
▁few 2.515625
▁dec 0.74560546875
ades 0.0005826950073242188
▁indicated 9.4296875
▁the 2.091796875
▁growing 4.69921875
▁concern 3.599609375
▁regarding 2.873046875
▁op 3.607421875
iate 0.76318359375
▁ab 1.5283203125
use 0.00848388671875
▁in 3.4296875
▁forms 10.6484375
▁of 0.412109375
▁over 3.271484375
d 0.4111328125
ose 0.169677734375
▁and 0.69677734375
▁add 1.123046875
iction 0.027069091796875
. 0.20703125
▁A 3.984375
▁more 5.6953125
▁manage 9.0546875
able 0.00867462158203125
▁and 2.26171875
▁sa 2.310546875
fer 0.0006842613220214844
▁alternative 1.6796875
▁might 6.41796875
▁be 0.188232421875
▁medical 2.705078125
▁mar 0.15380859375
iju 0.006252288818359375
ana 0.001476287841796875
. 1.5341796875
▁However 2.82421875
, 0.00807952880859375
▁the 1.611328125
▁legal 4.15234375
▁status 1.16796875
▁and 2.748046875
▁novel 9.3046875
ty 0.64892578125
▁of 0.2105712890625
▁this 1.6513671875
▁drug 2.068359375
▁do 5.04296875
▁not 0.0714111328125
▁allow 1.072265625
▁finding 8.78125
▁a 2.33984375
▁large 4.31640625
▁number 1.455078125
▁of 0.00528717041015625
▁studies 1.3359375
▁on 1.54296875
▁its 0.9794921875
▁effect 2.068359375
iveness 0.47265625
. 0.96044921875
▁Specifically 8.2578125
, 0.12091064453125
▁it 2.71484375
▁concerns 4.7890625
▁the 0.6494140625
▁emot 7.33203125
ional 0.0179443359375
▁condition 5.44921875
▁of 0.39306640625
▁patients 0.865234375
▁experien 6.4375
cing 0.0003731250762939453
▁chron 1.1513671875
ic 0.0033512115478515625
▁pain 0.0938720703125
. 0.6357421875
▁This 3.14453125
▁research 2.974609375
▁paper 6.2578125
▁a 2.185546875
ims 0.0005860328674316406
▁to 0.1026611328125
▁analyze 3.115234375
▁levels 9.578125
▁of 0.035614013671875
▁de 0.560546875
pression 0.03717041015625
▁and 0.257080078125
▁anx 0.0452880859375
iety 0.0021228790283203125
▁among 0.7255859375
▁people 2.833984375
▁receiving 0.7529296875
▁ther 7.91796875
apy 0.37158203125
▁by 5.16015625
▁comparing 8.2421875
▁the 1.0771484375
▁effects 2.177734375
▁of 0.03167724609375
▁ph 2.45703125
arma 0.04693603515625
ce 0.001888275146484375
ut 0.0005826950073242188
ical 0.003604888916015625
▁op 0.310791015625
io 0.15673828125
ids 0.056976318359375
▁and 0.277587890625
▁MM 1.63671875
. 1.009765625
<0x0A> 1.05859375
The 1.3662109375
▁study 2.076171875
▁was 2.123046875
▁conducted 0.75
▁in 1.5712890625
▁the 1.4619140625
▁form 2.046875
▁of 0.0093994140625
▁collection 10.125
▁and 1.6748046875
▁analysis 0.68310546875
▁of 0.042633056640625
▁statistical 4.234375
▁data 0.119384765625
. 0.92578125
▁Part 4.83984375
icip 0.0687255859375
ants 0.04534912109375
▁were 0.70361328125
▁rec 3.046875
ru 0.0017032623291015625
ited 0.00031495094299316406
▁for 4.06640625
▁six 7.46875
▁months 0.5224609375
▁at 3.818359375
▁two 2.564453125
▁major 5.703125
▁pain 2.787109375
▁relief 5.37890625
▁cent 1.533203125
ers 0.066162109375
▁in 0.7060546875
▁Israel 4.3984375
. 0.4267578125
▁The 1.2099609375
▁research 2.14453125
ers 1.482421875
▁used 2.6484375
▁The 7.98046875
▁De 4.2265625
pression 0.016998291015625
▁Module 10.0390625
▁of 0.9287109375
▁the 0.3134765625
▁Pat 2.232421875
ient 0.0169830322265625
▁Health 0.098388671875
▁Question 0.01558685302734375
naire 0.0217742919921875
▁and 3.365234375
▁the 0.71435546875
▁General 1.755859375
ized 0.7529296875
▁An 0.0159759521484375
x 0.0002300739288330078
iety 0.003269195556640625
▁Dis 0.53125
order 0.036865234375
▁Sc 1.220703125
ale 0.06988525390625
▁to 1.724609375
▁interview 7.01171875
▁participants 1.986328125
, 3.6875
▁evaluate 5.54296875
▁their 0.72021484375
▁answers 6.52734375
, 0.875
▁and 0.144775390625
▁conduct 4.44921875
▁the 2.3046875
▁study 2.3046875
. 0.2310791015625
▁To 5.1015625
▁specifically 9.890625
▁evaluate 2.568359375
▁and 4.3671875
▁compare 0.93994140625
▁the 0.34130859375
▁prob 11.109375
abilities 0.181884765625
▁of 0.1295166015625
▁de 0.82958984375
pression 0.0357666015625
▁or 4.62890625
▁anx 0.037689208984375
iety 0.00069427490234375
▁among 1.66015625
▁the 2.224609375
▁diverse 8.8125
▁groups 1.533203125
, 1.4345703125
▁the 1.0087890625
▁study 2.693359375
▁used 1.6171875
▁multiple 4.69921875
▁log 2.8671875
istic 0.037506103515625
▁regression 0.0994873046875
▁analysis 0.66943359375
▁and 2.53515625
▁chose 8.9453125
▁medical 7.49609375
▁mar 0.351806640625
iju 0.00360870361328125
ana 0.0007123947143554688
▁as 0.80126953125
▁the 1.0576171875
▁control 2.66796875
▁group 0.5517578125
. 0.292724609375
<0x0A> 0.77294921875
This 3.486328125
▁type 6.109375
▁of 0.0081634521484375
▁study 1.72265625
▁is 1.267578125
▁the 3.384765625
▁most 1.90625
▁reve 9.140625
aling 0.0010118484497070312
▁and 1.05859375
▁inclus 6.48046875
ive 0.0028972625732421875
, 2.3203125
▁as 1.8955078125
▁it 0.347412109375
▁contains 4.94140625
▁direct 6.38671875
▁responses 4.96484375
▁from 0.82373046875
▁a 3.853515625
▁large 0.92138671875
▁number 0.4365234375
▁of 0.0037136077880859375
▁participants 1.435546875
. 0.640625
▁All 4.640625
▁tools 9.078125
▁in 4.55078125
▁the 0.6767578125
▁form 3.529296875
▁of 0.0408935546875
▁question 1.7490234375
na 0.033416748046875
ires 0.00021207332611083984
▁and 2.09765625
▁scales 3.09375
▁have 3.67578125
▁already 4.47265625
▁been 0.1806640625
▁used 1.919921875
▁and 2.091796875
▁proved 4.1875
▁their 1.7666015625
▁effic 3.865234375
acy 0.00014448165893554688
▁for 3.62890625
▁collect 4.625
ing 0.017578125
▁analyt 8.2578125
ical 0.243896484375
▁data 0.269775390625
. 0.42529296875
▁It 3.548828125
▁helps 4.7734375
▁to 0.9580078125
▁system 7.33203125
at 1.275390625
ize 0.00908660888671875
▁and 1.5810546875
▁class 4.06640625
ify 0.0024662017822265625
▁distinct 9.2265625
▁kinds 6.27734375
▁of 0.0256195068359375
▁information 3.47265625
▁for 3.91015625
▁subsequent 4.08203125
▁un 7.98828125
comp 5.50390625
licated 0.06585693359375
▁services 11.78125
. 0.654296875
▁Thus 4.36328125
, 0.023193359375
▁research 4.47265625
ers 0.51708984375
▁can 1.3701171875
▁compare 3.962890625
▁the 0.958984375
▁effects 2.951171875
▁of 0.1058349609375
▁medic 4.4140625
ations 0.884765625
▁on 1.8173828125
▁patients 2.130859375
▁of 4.58203125
▁diverse 3.931640625
▁age 2.7421875
▁groups 0.66748046875
, 0.92041015625
▁background 5.00390625
s 0.2147216796875
, 0.07037353515625
▁physical 5.41015625
▁conditions 1.4189453125
, 0.08599853515625
▁emot 5.484375
ional 0.064697265625
▁states 1.3857421875
, 0.1041259765625
▁and 0.43798828125
▁so 3.181640625
▁on 0.317626953125
. 0.09130859375
<0x0A> 0.66845703125
The 1.0927734375
▁analysis 4.51953125
▁of 0.58349609375
▁any 8.8984375
▁human 6.03125
▁re 7.22265625
at 10.109375
cion 11.2421875
▁has 4.1953125
▁a 1.80859375
▁high 4.30078125
▁potential 3.365234375
▁of 1.5517578125
▁subject 5.28515625
iveness 3.888671875
▁and 1.384765625
▁bias 2.060546875
, 1.90625
▁especially 2.4609375
▁regarding 4.51953125
▁people 4.6484375
▁in 4.05859375
▁severe 4.38671875
▁pain 0.29541015625
▁and 2.587890625
▁un 5.3828125
stable 1.8466796875
▁emot 1.0205078125
ional 0.1544189453125
▁condition 2.568359375
. 0.07958984375
▁Perhaps 8.890625
▁some 4.93359375
▁patients 2.322265625
▁tend 5.5234375
▁to 0.02294921875
▁ex 2.701171875
agger 0.0031871795654296875
ate 0.009033203125
▁their 0.7236328125
▁de 5.19140625
press 1.61328125
ive 0.280029296875
▁state 3.162109375
▁or 1.810546875
▁vice 7.32421875
▁vers 0.0262603759765625
a 0.0010328292846679688
, 1.0830078125
▁de 7.546875
- 4.55078125
emph 0.98095703125
as 0.0106353759765625
ize 0.173583984375
▁serious 6.75
▁difficulties 5.87890625
. 0.890625
▁Because 6.14453125
▁the 2.349609375
▁survey 6.01953125
▁responses 6.75390625
▁w 11.5625
ero 4.52734375
e 9.6328125
▁thoroughly 7.09375
▁anonymous 5.75390625
, 0.50634765625
▁the 1.5009765625
▁research 1.48046875
ers 0.274658203125
▁were 1.7099609375
▁unable 2.173828125
▁to 0.0301055908203125
▁carefully 8.6328125
▁analyze 1.63671875
▁each 4.07421875
▁patient 2.5859375
’ 26.09375
s 1.056640625
▁reaction 4.30859375
▁and 2.478515625
▁compare 3.58203125
▁it 1.041015625
▁to 1.236328125
▁the 0.75146484375
▁actual 5.33984375
▁states 7.18359375
▁of 0.71826171875
▁condition 7.3203125
. 0.353271484375
▁More 6.890625
▁accurate 3.953125
▁answers 4.671875
▁could 2.57421875
▁be 0.86767578125
▁obtained 1.0009765625
▁by 1.4091796875
▁professional 7.43359375
▁psych 2.25
olog 0.3515625
ists 0.007007598876953125
▁via 7.9375
▁personal 3.8828125
▁communication 4.6953125
▁and 1.75390625
▁behavior 7.2109375
al 0.314208984375
▁analysis 2.263671875
. 0.2347412109375
▁However 2.740234375
, 0.0040283203125
▁this 1.8828125
▁method 2.8359375
▁of 2.30078125
▁research 2.14453125
▁is 0.85595703125
▁way 7.7578125
▁more 1.5849609375
▁resource 6.78515625
- 0.451904296875
int 0.56640625
ensive 0.01105499267578125
▁and 0.60302734375
▁energy 8.6484375
- 0.1353759765625
consum 0.308349609375
ing 0.004993438720703125
. 0.5908203125
<0x0A> 0.64794921875
Part 5.48828125
icip 0.09405517578125
ants 0.1407470703125
▁were 0.99365234375
▁rec 1.5791015625
ru 0.004192352294921875
ited 0.001194000244140625
▁for 1.212890625
▁six 1.2646484375
▁months 0.02642822265625
▁at 0.477783203125
▁two 0.12127685546875
▁major 0.36572265625
▁pain 0.041778564453125
▁relief 0.03228759765625
▁cent 0.02679443359375
ers 0.0186614990234375
▁in 0.0679931640625
▁Israel 0.03521728515625
. 0.1517333984375
▁All 3.478515625
▁patients 1.6220703125
▁experienced 5.4375
▁chron 2.001953125
ic 0.0035839080810546875
▁pain 0.10125732421875
▁for 3.328125
▁at 0.7578125
▁least 0.00357818603515625
▁ 1.0517578125
3 1.4580078125
▁months 0.2344970703125
. 1.015625
▁The 1.4794921875
▁study 1.9736328125
▁included 2.154296875
▁ 1.111328125
8 2.890625
9 2.75
0 3.474609375
▁participants 1.537109375
, 1.2392578125
▁of 1.7744140625
▁which 0.424072265625
▁ 0.1466064453125
4 1.6162109375
7 2.462890625
4 2.76953125
▁( 2.173828125
5 0.10595703125
9 11.046875
%) 1.0234375
▁were 0.52197265625
▁treated 4.703125
▁sole 7.140625
ly 0.00034546852111816406
▁with 0.48388671875
▁op 0.828125
io 0.453125
ids 0.1842041015625
, 1.169921875
▁ 0.61474609375
3 1.0693359375
2 2.134765625
9 2.533203125
▁( 0.048492431640625
4 1.2119140625
1 1.251953125
%) 0.14306640625
▁were 1.3369140625
▁treated 0.541015625
▁with 0.1700439453125
▁MM 0.9404296875
, 0.272705078125
▁and 0.1513671875
▁ 0.1453857421875
7 3.25
7 2.421875
▁( 0.189453125
8 3.828125
. 1.154296875
6 2.958984375
%) 0.060546875
▁acquired 9.75
▁both 1.1083984375
▁( 6.94921875
Fe 10.1640625
ing 2.947265625
old 0.0189056396484375
▁et 1.392578125
▁al 0.0307769775390625
., 0.30908203125
▁ 0.0140838623046875
2 0.1497802734375
0 0.0006494522094726562
1 0.385498046875
7 2.068359375
). 0.1353759765625
▁The 1.3564453125
▁remaining 7.0625
▁ten 8.203125
▁participants 1.3525390625
▁who 5.51171875
▁did 1.4462890625
▁not 0.0108184814453125
▁receive 1.74609375
▁ph 2.900390625
arma 0.059539794921875
ce 0.0023174285888671875
ut 0.0007510185241699219
ical 0.0041656494140625
▁op 0.96142578125
io 0.0938720703125
ids 0.024383544921875
▁and 1.63671875
▁medical 2.0390625
▁mar 0.042083740234375
iju 0.0161895751953125
ana 0.0007405281066894531
▁were 1.3134765625
▁with 6.03125
dra 0.1790771484375
wn 0.0007863044738769531
▁from 0.265380859375
▁the 0.108642578125
▁analysis 4.59375
▁in 4.828125
▁the 1.1806640625
▁research 4.328125
. 0.7236328125
▁Therefore 4.8828125
, 0.0089874267578125
▁it 3.75
▁is 0.91650390625
▁not 2.71875
▁possible 0.75341796875
▁to 0.022918701171875
▁compreh 6.59375
ens 0.0628662109375
ively 0.0256195068359375
▁compare 1.90625
▁patients 4.76171875
▁taking 4.3203125
▁medic 3.818359375
ations 0.44677734375
▁with 0.9345703125
▁those 1.1064453125
▁who 1.1767578125
▁do 1.7314453125
▁not 0.01030731201171875
. 0.77880859375
<0x0A> 0.67041015625
The 1.115234375
▁study 1.7275390625
▁conducted 4.8046875
▁a 2.072265625
▁corre 14.8046875
ation 11.421875
▁type 7.22265625
▁of 0.452880859375
▁research 1.9619140625
▁with 2.875
▁variable 7.796875
▁measures 4.21875
. 1.1591796875
▁It 2.048828125
▁evaluated 4.76171875
▁the 0.65478515625
▁inter 6.85546875
dep 3.73046875
end 0.0089874267578125
ence 0.025360107421875
▁of 0.541015625
▁various 3.908203125
▁factors 1.7861328125
▁that 2.677734375
▁affected 4.078125
▁the 0.55029296875
▁physical 7.20703125
▁and 0.9150390625
▁emot 0.436767578125
ional 0.0007348060607910156
▁condition 1.0341796875
▁of 0.13232421875
▁patients 0.68603515625
▁experien 4.40625
cing 0.000667572021484375
▁chron 0.6494140625
ic 0.0009379386901855469
▁pain 0.0284423828125
. 0.23291015625
▁For 3.8203125
▁example 1.146484375
, 0.01441192626953125
▁the 1.24609375
▁survey 5.30859375
▁showed 3.583984375
▁that 0.322998046875
▁the 1.74609375
▁ratio 7.16796875
▁of 0.1318359375
▁female 4.2890625
▁patients 0.86279296875
▁was 1.8095703125
▁remark 9.375
ably 0.0030364990234375
▁higher 0.552734375
▁in 2.685546875
▁the 0.9736328125
▁op 4.42578125
i 3.673828125
ates 0.22607421875
▁group 0.281982421875
▁compared 2.798828125
▁to 0.1258544921875
▁the 0.484130859375
▁MM 0.5498046875
▁group 0.295166015625
. 0.48681640625
▁In 2.984375
▁turn 4.04296875
, 0.003452301025390625
▁people 5.9296875
▁on 5.49609375
▁op 1.3955078125
i 0.46142578125
ates 0.007099151611328125
▁were 1.09765625
▁more 1.005859375
▁likely 0.3984375
▁to 0.0634765625
▁report 3.220703125
▁major 5.98046875
▁de 0.412109375
press 1.21875
ive 0.00519561767578125
▁dis 0.50830078125
orders 1.466796875
. 1.81640625
<0x0A> 2.525390625
The 1.1240234375
▁question 5.75
na 1.1962890625
ires 0.0007290840148925781
▁used 2.025390625
▁different 8.1484375
▁variable 8.8046875
▁measures 0.90625
▁to 1.400390625
▁collect 2.4140625
▁information 2.00390625
. 1.689453125
▁For 1.87890625
▁example 0.19873046875
, 0.00775146484375
▁it 4.0234375
▁included 2.51171875
▁compreh 8.671875
ensive 0.0311431884765625
▁so 6.76171875
cio 0.057525634765625
- 0.521484375
dem 0.0933837890625
ographic 0.044708251953125
▁data 1.025390625
: 4.96875
▁gender 1.6240234375
, 0.08856201171875
▁age 0.21826171875
, 0.08837890625
▁country 4.34375
, 1.439453125
▁type 4.3515625
▁of 0.05517578125
▁residence 3.837890625
▁( 3.443359375
urban 2.025390625
/ 2.908203125
r 0.0660400390625
ural 0.001964569091796875
), 0.2415771484375
▁years 5.953125
▁of 0.1689453125
▁education 0.67724609375
, 0.14453125
▁and 1.8603515625
▁employ 3.6484375
ment 0.005359649658203125
▁status 0.455322265625
. 0.175537109375
▁Pat 3.845703125
ients 0.093505859375
▁were 1.1806640625
▁also 0.90625
▁asked 0.625
▁about 1.166015625
▁their 0.61767578125
▁medical 2.771484375
▁history 0.4150390625
▁over 8.765625
▁the 0.169921875
▁years 3.935546875
▁and 1.7939453125
▁the 1.84375
▁current 3.375
▁presence 5.8203125
▁of 0.05426025390625
▁any 2.6875
▁severe 4.62890625
▁dise 1.48046875
ases 0.0002923011779785156
▁such 4.2109375
▁as 0.006168365478515625
▁heart 2.419921875
▁failure 2.033203125
, 0.1834716796875
▁di 1.873046875
ab 0.002468109130859375
etes 0.005260467529296875
, 0.1214599609375
▁ar 3.748046875
th 0.134033203125
rit 0.039886474609375
is 0.0137176513671875
, 0.0433349609375
▁and 1.5703125
▁so 0.76806640625
▁on 0.03509521484375
. 0.050567626953125
▁The 1.892578125
▁third 7.2421875
▁measure 3.828125
▁of 2.056640625
▁the 0.97509765625
▁question 2.845703125
naire 0.1966552734375
▁was 1.00390625
▁indicated 9.765625
▁by 0.6435546875
▁information 6.640625
▁on 1.580078125
▁any 5.3671875
▁twelve 13.609375
- 1.1865234375
month 0.355712890625
▁and 5.80078125
▁lifetime 3.177734375
▁drug 4.7265625
▁and 3.5078125
▁alco 0.07781982421875
hol 0.0002391338348388672
▁consumption 2.61328125
. 0.46484375
▁In 3.466796875
▁addition 0.79736328125
, 0.11993408203125
▁the 1.1494140625
▁record 7.9453125
▁included 1.822265625
▁a 2.484375
▁pain 6.3984375
▁measurement 4.23828125
▁scale 1.0439453125
▁from 3.60546875
▁ 0.4521484375
0 0.431640625
▁to 0.421875
▁ 0.008056640625
1 0.087646484375
0 0.075439453125
▁to 4.640625
▁evaluate 1.48828125
▁dis 5.92578125
com 0.2178955078125
fort 0.0034809112548828125
▁feelings 7.3671875
▁during 3.306640625
▁the 0.8916015625
▁last 1.4306640625
▁month 1.572265625
. 0.28515625
<0x0A> 1.1611328125
Am 6.8984375
ong 0.015045166015625
▁all 2.31640625
▁participants 1.9248046875
▁in 3.548828125
▁the 0.1739501953125
▁study 0.378662109375
, 0.056427001953125
▁ 0.64501953125
4 1.7705078125
2 2.724609375
. 1.791015625
2 2.3046875
% 0.146240234375
▁suffered 4.87890625
▁from 0.13427734375
▁de 1.775390625
pression 0.166015625
, 1.072265625
▁and 1.7978515625
▁ 0.1456298828125
3 1.7177734375
7 2.23046875
% 2.728515625
▁experienced 2.291015625
▁excess 7.828125
ive 0.09161376953125
▁anx 0.262451171875
iety 0.0025196075439453125
. 0.34716796875
▁The 1.4248046875
▁pl 11.21875
ur 1.033203125
ality 0.0003745555877685547
▁of 0.189453125
▁de 3.521484375
press 1.2939453125
ive 0.02734375
▁dis 1.798828125
orders 0.06219482421875
▁among 3.826171875
▁patients 1.248046875
▁in 3.60546875
▁the 0.359130859375
▁op 1.427734375
i 0.8955078125
ates 0.0076141357421875
, 7.08203125
▁medical 2.732421875
▁mar 0.0210113525390625
iju 0.0153045654296875
ana 0.00012040138244628906
, 0.10919189453125
▁and 0.06365966796875
▁mixed 5.94921875
▁OP 8.8125
MM 5.87109375
▁groups 0.466796875
▁number 8.1484375
ed 0.0104827880859375
▁ 0.118896484375
5 2.201171875
7 2.490234375
. 0.20458984375
1 2.369140625
%, 0.25048828125
▁ 0.005062103271484375
2 3.013671875
2 2.435546875
. 0.099853515625
3 2.2265625
%, 0.1180419921875
▁and 0.03369140625
▁ 0.0032291412353515625
5 3.21875
1 2.556640625
. 0.1646728515625
4 2.150390625
%, 0.388916015625
▁respectively 0.01209259033203125
. 0.2822265625
▁The 1.4775390625
▁pl 4.515625
ur 0.024749755859375
ality 7.271766662597656e-05
▁of 0.04095458984375
▁anx 0.92724609375
iety 0.0146636962890625
▁contained 10.984375
▁ 0.55712890625
4 1.578125
8 2.376953125
. 0.061920166015625
4 2.306640625
% 0.509765625
▁among 1.4853515625
▁OP 6.43359375
▁patients 8.953125
, 0.266845703125
▁ 0.09564208984375
2 1.509765625
1 2.419921875
. 0.129638671875
5 2.421875
% 0.01149749755859375
▁among 0.42919921875
▁MM 0.345947265625
▁patients 0.244384765625
, 0.01171875
▁and 0.013824462890625
▁ 0.03839111328125
3 1.2333984375
8 2.6484375
. 0.1561279296875
7 2.29296875
% 0.0135498046875
▁among 0.23486328125
▁OP 4.11328125
MM 0.259765625
▁participants 3.55859375
. 0.224853515625
▁Pat 5.62890625
ients 0.0259552001953125
▁who 2.392578125
▁took 2.958984375
▁strong 8.171875
▁op 1.2314453125
i 1.3037109375
ates 0.004673004150390625
▁were 1.775390625
▁t 8.8046875
ended 1.1318359375
▁to 0.01541900634765625
▁place 10.3828125
▁their 3.689453125
▁pain 2.623046875
▁on 3.423828125
▁a 0.8671875
▁scale 2.314453125
▁of 0.650390625
▁ 0.345703125
9 2.818359375
▁to 1.380859375
▁ 0.0162353515625
1 0.0230560302734375
0 0.0926513671875
▁( 2.53515625
Fe 1.6767578125
ing 0.0094451904296875
old 0.0009212493896484375
▁et 0.0279541015625
▁al 0.0020351409912109375
., 0.007568359375
▁ 0.00231170654296875
2 0.0005598068237304688
0 6.401538848876953e-05
1 0.00212860107421875
7 0.01399993896484375
). 0.052947998046875
▁They 4.71875
▁were 1.287109375
▁also 1.3544921875
▁an 8.8125
gu 4.375
ished 0.048828125
▁em 8.4375
otion 0.0223846435546875
ally 0.00518035888671875
▁and 1.115234375
▁react 6.8125
ed 0.059906005859375
▁rad 9.5234375
ically 0.016571044921875
▁neg 5.31640625
atively 0.00168609619140625
▁to 0.327392578125
▁almost 5.28125
▁all 1.203125
▁survey 8.3828125
▁questions 0.625
. 0.29833984375
▁Pat 4.11328125
ients 0.00878143310546875
▁who 1.1669921875
▁took 1.5380859375
▁only 5.47265625
▁MM 0.90478515625
▁or 3.2265625
▁mixed 3.447265625
▁medic 2.57421875
ations 0.322509765625
▁course 12.5234375
▁had 2.447265625
▁a 1.2666015625
▁significantly 2.5703125
▁more 4.07421875
▁stable 3.3359375
▁emot 1.1669921875
ional 0.00839996337890625
▁state 0.82373046875
▁and 1.3916015625
▁cop 5.46875
ed 0.90283203125
▁with 0.732421875
▁pain 1.462890625
▁more 1.68359375
▁manage 6.9375
able 2.353515625
. 0.52783203125
<0x0A> 0.701171875
One 5.15625
▁of 0.57080078125
▁the 0.0189361572265625
▁major 2.556640625
▁limitations 2.693359375
▁is 3.880859375
▁the 0.5087890625
▁ins 4.78515625
u 0.0191650390625
fficient 0.1331787109375
ly 4.72265625
▁high 3.001953125
▁response 3.015625
▁rate 0.11981201171875
, 2.650390625
▁ 4.53125
5 1.927734375
7 2.0703125
% 2.1015625
▁instead 7.265625
▁of 0.007244110107421875
▁ 0.70263671875
7 1.4921875
0 1.45703125
% 1.1005859375
▁( 1.583984375
Fe 0.27294921875
ing 0.004909515380859375
old 0.0009684562683105469
▁et 0.006816864013671875
▁al 0.0014858245849609375
., 0.00525665283203125
▁ 0.0018672943115234375
2 0.00045990943908691406
0 2.9921531677246094e-05
1 0.0012521743774414062
7 0.00753021240234375
). 0.039459228515625
▁It 2.67578125
▁can 3.287109375
▁be 0.41162109375
▁fairly 8.4140625
▁explained 1.427734375
▁by 0.1717529296875
▁the 0.32958984375
▁weak 8.1875
▁focus 7.125
▁of 0.452392578125
▁respond 6.3515625
ents 0.1351318359375
▁who 3.51953125
▁have 4.078125
▁overcome 8.0546875
▁severe 2.248046875
▁pain 0.497802734375
▁sens 8.671875
ations 1.1201171875
▁and 1.189453125
▁de 4.23046875
press 1.7646484375
ive 0.23974609375
▁episodes 4.04296875
. 0.60205078125
▁It 3.369140625
▁is 0.8330078125
▁not 2.630859375
▁clear 4.25390625
▁how 1.6875
▁to 3.56640625
▁use 5.375
▁these 3.021484375
▁statistics 3.41015625
, 2.546875
▁as 1.439453125
▁they 1.3564453125
▁still 6.0859375
▁may 4.8359375
▁be 1.3359375
▁relevant 5.26171875
▁for 1.3828125
▁the 1.8310546875
▁overall 4.453125
▁analysis 2.98046875
. 1.0361328125
